ReviewEcho research and practice2024
Echocardiographic assessment of aortic regurgitation: a narrative review.
Review in Echo research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 14 citations in OpenAlex.
- Article
- Role of Cardiac CT in the Evaluation of Valvular Heart Disease.Journal of the Korean Society of Radiology · 2026Review
- Prevalence of Congenital Aortic Valve Regurgitation in a Newborn Cohort.Pediatric cardiology · 2026Article
- Holodiastolic Murmur following Blunt Chest Trauma: Rapid Clinical Deterioration due to Aortic Valve Perforation.CASE (Philadelphia, Pa.) · 2025Article
- Comparison of TAVR and SAVR in elderly patients with pure native aortic regurgitation: outcomes and midterm results.Cardiovascular diagnosis and therapy · 2025Article
- Global trends and research hotspots in transcatheter valve replacement for aortic regurgitation: a bibliometric and visualized analysis.Journal of cardiothoracic surgery · 2025Article
- Longitudinal Myocardial Deformation as an Emerging Biomarker for Post-Traumatic Cardiac Dysfunction.Life (Basel, Switzerland) · 2025Review
- Echocardiographic assessment of aortic regurgitation: a practical guideline from the British Society of Echocardiography.Echo research and practice · 2025Review
- Incidence and Pathology of Aortic Regurgitation.Interventional cardiology (London, England) · 2025Review
- Bioengineered heart valves for personalized therapy: advances in manufacturing and clinical challenges.Frontiers in bioengineering and biotechnology · 2025Review
- Aortic Regurgitation: From Valvular to Myocardial Dysfunction.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aortic regurgitation (AR) is the third most frequently encountered valve lesion and may be caused by abnormalities of the valve cusps or the aorta. Echocardiography is instrumental in the assessment of AR as it enables the delineation of valvular morphology, the mechanism of the lesion and the grading of severity. Severe AR has a major impact on the myocardium and carries a significant risk of morbidity and mortality if left untreated. Established and novel echocardiographic methods, such as global longitudinal strain and three-dimensional echocardiography, allow an estimation of this risk and provide invaluable information for patient management and prognosis. This narrative review summarises the epidemiology of AR, reviews current practices and recommendations with regards to the echocardiographic assessment of AR and outlines novel echocardiographic tools that may prove beneficial in patient assessment and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.